Open AccessSafety and tolerability of PD-1/PD-L1 inhibitors in elderly and frail patients with advanced malignancies
Author(s) -
Tomoki Sakakida,
Takeshi Ishikawa,
Junji Uchino,
Yusuke Tabuchi,
Satoshi Komori,
Jun Asai,
Akihito Arai,
Hiroaki Tsunezuka,
Toshiyuki Kosuga,
Hirotaka Konishi,
Fumiya Hongo,
Masayoshi Inoue,
Shigeru Hirano,
Osamu Ukimura,
Tetsuya Taguchi,
Koichi Takayama,
Yoshito Itoh
Publication year - 2020
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2020.11875
Subject(s) - tolerability , medicine , discontinuation , atezolizumab , adverse effect , population , nivolumab , cancer , immunotherapy , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom